e-learning
resources
Glasgow 2004
Wednesday 08.09.2004
Management and resistance in tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The clinical effect of combined therapy according to guidelines on the treatment of pulmonary
Mycobacterium avium
complex disease - including a long-term follow-up study
Y. Kobashi, T. Matsushima (Kurashiki City, Japan)
Source:
Annual Congress 2004 - Management and resistance in tuberculosis
Session:
Management and resistance in tuberculosis
Session type:
Poster Discussion
Number:
4418
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Kobashi, T. Matsushima (Kurashiki City, Japan). The clinical effect of combined therapy according to guidelines on the treatment of pulmonary
Mycobacterium avium
complex disease - including a long-term follow-up study. Eur Respir J 2004; 24: Suppl. 48, 4418
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
The effect of combined chemotherapy according to the guidelines on the treatment for
Mycobacterium avium
complex pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 546s
Year: 2002
Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy following the guidelines for treatment
Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Year: 2009
The impact of different antibiotic treatment regimens on mortality in
Mycobacterium avium
complex pulmonary disease: a population-based cohort study
Source: Eur Respir J, 56 (3) 1901875; 10.1183/13993003.01875-2019
Year: 2020
Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systemic review and meta-analysis
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment
Source: Eur Respir J 2003; 21: 478-482
Year: 2003
Clinical effect of combined chemotherapy according to guidelines fro the treatment of pulmonary Mtcobacterium complex disease, including a follow-up study.
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019
Clinical efficacy and safety of fluoroquinolone containing regimens in patients with
Mycobacterium avium
complex pulmonary disease
Source: Eur Respir J, 55 (4) 1901240; 10.1183/13993003.01240-2019
Year: 2020
Treatment of severe Mycobacterium avium complex pulmonary disease with a adjunctive amikacin and clofazimine versus standard regimen alone, a retrospective study
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection I
Year: 2019
Paradoxical response during antibiotic treatment in patients with Mycobacterium avium complex lung disease
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020
Impact of smoking on outcome of treatment of tuberculosis in patients taking intermittent treatment of tuberculosis under India‘s revised tuberculosis control program
Source: Annual Congress 2008 - Health effects of passive smoking and of a smoking ban
Year: 2008
Failure with acquired resistance of an optimised bedaquiline-based treatment regimen for pulmonary
Mycobacterium avium
complex disease
Source: Eur Respir J, 54 (1) 1900118; 10.1183/13993003.00118-2019
Year: 2019
Association between injectable aminoglycoside treatment duration and outcomes in cavitary Mycobacterium avium complex lung disease
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018
The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses
Source: Eur Respir J 2001; 18: Suppl. 33, 473s
Year: 2001
Outcomes of
Mycobacterium avium
complex lung disease based on clinical phenotype
Source: Eur Respir J, 50 (3) 1602503; 10.1183/13993003.02503-2016
Year: 2017
Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease
Source: Eur Respir J 2009; 33: 148-152
Year: 2009
Comparison of two different cohorts of patients for multidrug-resistant tuberculosis treatment evaluation
Source: Annual Congress 2006 - Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB)
Year: 2006
A double blind randomized study of aminoglycoside infusion with combined therapy for pulmonary
mycobacterium avium
complex disease
Source: Annual Congress 2006 - Clinical epidemiology of tuberculosis
Year: 2006
Switch effects from daily to intermittent treatment with a daily regimen dosage for Mycobacterium avium complex pulmonary disease
Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection
Year: 2019
The clinical and bacteriological basis for initiating a specific treatment
Source: Annual Congress 2006 - PG11 - Clinical highlights on tuberculosis
Year: 2006
Factors related to response to intermittent treatment of
mycobacterium avium
complex lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 557s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept